Nano-X Imaging Ltd.(NNOX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

Nano-X Imaging Ltd. (NNOX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NNOX at 17.1/100 on a 32-signal composite quality model, placing it at rank #2,828 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Nano-X Imaging Ltd. reports quarterly revenue of $13.0M, net income of $-75.0M, free cash flow of $-45.0M. Top institutional holders of NNOX by reported 13-F value include UBS Group AG, ARK Investment Management, MARSHALL WACE, LLP, based on the most recent SEC filings. NNOX trades on the Nasdaq exchange and files with the SEC under CIK 1795251. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NNOX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nano-X Imaging Ltd. directly from SEC EDGAR.